Lallemand Health Solutions’ probiotic ingredient, L. rhamnosus HA-114, has been demonstrated to improve eating and mood-related behaviours in overweight adults undergoing diet-induced weight loss in a recent study.
The results of the randomised, double-blind, placebo-controlled clinical trial highlight the beneficial effects of this probiotic intervention for behavioural and psychological traits when engaging in a calorie reduced diet. A healthier metabolic phenotype was also associated with probiotic supplementation. The results support the applicability of the brain-gut axis concept and demonstrate the influence of this probiotic strain on psychological wellbeing among participants engaging in a caloric-restriction intervention.
“We are extremely excited about these new insights. L. rhamnosus HA-114 is an innovative strain that has shown its capacity to support weight management efforts in overweight adults undertaking a weight loss program. It will allow us to formulate unique probiotic solutions for our partners available in convenient galenic formats, such as caps, sachets, orodispersible stick, etc,” said Morgane Maillard, Marketing Group Manager at Lallemand Health Solutions.
“Consumers are health-aware and are looking for natural ways to take care of themselves, so the market opportunities are real. This study is paving the way to further investigation in the field of metabolic health, where there are abundant health applications.”
The probiotic could support wellness and facilitate adherence during a diet-based weight reduction program. The probiotic improved self-control behaviours related to binge-eating, hunger, food cravings, which researchers theorise could lead to a better long-term adherence to dietary recommendations and higher loss.
The company’s data suggests for 45.7% of consumers, losing weight is a challenge because they’re prone to self-defeating actions, like enjoying treats and moments of indulgence, while 28.9% of consumers think their latest attempt to lose weight was unsuccessful.
